At least one of these entry inhibitors—a biomimetic peptide called Enfuvirtide, or the brand name Fuzeon—has received FDA approval and has been in use for some time.
Salah satu entry inhibitor—peptida biomimetik dijual dengan nama dagang Fuzeon—telah menerima persetujuan FDA dan telah digunakan untuk beberapa waktu.